• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

咨询者对BRCA1/2基因中未分类变异的看法:回忆、解读及其对生活的影响。

The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life.

作者信息

Vos Joël, Otten Wilma, van Asperen Christi, Jansen Anna, Menko Fred, Tibben Aad

机构信息

Department of Clinical Genetics, Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

Psychooncology. 2008 Aug;17(8):822-30. doi: 10.1002/pon.1311.

DOI:10.1002/pon.1311
PMID:18157792
Abstract

OBJECTIVE

Unclassified variants (UVs, variants of uncertain clinical significance) are found in 13% of all BRCA1/2 mutation analyses. Little is known about the counsellees' recall and interpretation of a UV, and its psychosocial/medical impact.

METHOD

Retrospective semi-structured interviews with open questions and five-point Likert scales were carried out in 24 counsellees who received a UV result 3 years before (sd=1.9).

RESULTS

Sixty-seven percent (16/24) recalled the UV result as a non-informative DNA result; 29% recalled a pathogenic result. However, 79% of all counsellees interpreted the UV result as a genetic predisposition for cancer. Variations in recall and interpretation were unexplained by demographics, cancer history of themselves and relatives, and communication aspects of UV disclosure. Sixty-seven percent perceived genetic counselling as completed, whereas 71% expected to receive new DNA information. Although most counsellees reported that UV disclosure had changed their lives in general little, one in three counsellees reported large changes in specific life domains, especially in surveillance behavior and medical decisions. Ten out of 19 participants who interpreted the UV as pathogenic had undergone preventive surgery against none of the 5 counsellees who interpreted the UV as non-informative.

CONCLUSION

Counsellors and researchers need to address discrepancies between the counsellees' factual recall and their subjective interpretation of non-informative BRCA1/2-test results.

摘要

目的

在所有BRCA1/2突变分析中,13%发现了未分类变异(UVs,临床意义不确定的变异)。对于接受咨询者对UV的回忆、解读及其心理社会/医学影响知之甚少。

方法

对24名在3年前(标准差=1.9)收到UV结果的接受咨询者进行了带有开放式问题和五点李克特量表的回顾性半结构化访谈。

结果

67%(16/24)的人将UV结果回忆为无信息的DNA结果;29%的人回忆为致病结果。然而,79%的接受咨询者将UV结果解读为癌症的遗传易感性。人口统计学、自身及亲属的癌症病史以及UV披露的沟通方面无法解释回忆和解读的差异。67%的人认为遗传咨询已完成,而71%的人期望获得新的DNA信息。尽管大多数接受咨询者报告称UV披露总体上对他们的生活影响不大,但三分之一的接受咨询者报告在特定生活领域有很大变化,尤其是在监测行为和医疗决策方面。将UV解读为致病的19名参与者中有10人接受了预防性手术,而将UV解读为无信息的5名接受咨询者中无人接受预防性手术。

结论

咨询师和研究人员需要解决接受咨询者对无信息的BRCA1/2检测结果的事实回忆与主观解读之间的差异。

相似文献

1
The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life.咨询者对BRCA1/2基因中未分类变异的看法:回忆、解读及其对生活的影响。
Psychooncology. 2008 Aug;17(8):822-30. doi: 10.1002/pon.1311.
2
Perceiving cancer-risks and heredity-likelihood in genetic-counseling: how counselees recall and interpret BRCA 1/2-test results.在遗传咨询中感知癌症风险和遗传可能性:被咨询者如何回忆和解释 BRCA1/2 测试结果。
Clin Genet. 2011 Mar;79(3):207-18. doi: 10.1111/j.1399-0004.2010.01581.x. Epub 2010 Nov 28.
3
Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.打开基因咨询中的心理黑箱。DNA 检测的心理影响由被咨询者的感知预测,而医学影响则由致病性或无信息的 BRCA1/2 结果预测。
Psychooncology. 2012 Jan;21(1):29-42. doi: 10.1002/pon.1864. Epub 2010 Nov 11.
4
Patients with an unclassified genetic variant in the BRCA1 or BRCA2 genes show different clinical features from those with a mutation.携带BRCA1或BRCA2基因未分类遗传变异的患者表现出与携带突变的患者不同的临床特征。
J Clin Oncol. 2005 Apr 1;23(10):2185-90. doi: 10.1200/JCO.2005.07.013.
5
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.在西班牙前往遗传咨询机构的BRCA1和BRCA2基因发生突变的携带者患乳腺癌和卵巢癌的平均累积风险。
Clin Cancer Res. 2008 May 1;14(9):2861-9. doi: 10.1158/1078-0432.CCR-07-4436.
6
Subjective interpretation of inconclusive BRCA1/2 cancer genetic test results and transmission of information to the relatives.BRCA1/2癌症基因检测结果不确定的主观解读及信息向亲属的传递
Psychooncology. 2009 Feb;18(2):209-15. doi: 10.1002/pon.1407.
7
Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene.使用患者RNA的逆转录PCR和基于剪接报告基因小基因的体外试验筛选BRCA1和BRCA2未分类变异的剪接突变。
J Med Genet. 2008 Jul;45(7):438-46. doi: 10.1136/jmg.2007.056895. Epub 2008 Apr 18.
8
A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling.一项将乳腺癌/卵巢癌基因检测决策辅助工具用作遗传咨询期间沟通辅助工具的随机试验。
Psychooncology. 2008 Aug;17(8):844-54. doi: 10.1002/pon.1353.
9
Using genetic analysis to individualize preventive measures for breast and ovarian cancers.利用基因分析为乳腺癌和卵巢癌个体化预防措施。
Nat Clin Pract Oncol. 2006 Apr;3(4):182-3. doi: 10.1038/ncponc0456.
10
Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.种族/族裔对遗传性乳腺癌和卵巢癌遗传咨询与检测的影响。
Breast J. 2009 Sep-Oct;15 Suppl 1:S56-62. doi: 10.1111/j.1524-4741.2009.00798.x.

引用本文的文献

1
The Development and Evaluation of Novel Patient Educational Material for a Variant of Uncertain Significance (VUS) Result in Hereditary Cancer Genes.新型遗传性癌症基因突变不确定意义(VUS)患者教育材料的开发与评估。
Curr Oncol. 2024 Jun 16;31(6):3361-3378. doi: 10.3390/curroncol31060256.
2
An overview of actionable and potentially actionable TSC1 and TSC2 germline variants in an online Database.在线数据库中可操作和潜在可操作的TSC1和TSC2种系变体概述。
Genet Mol Biol. 2024 Feb 19;46(3 Suppl 1):e20230132. doi: 10.1590/1678-4685-GMB-2023-0132. eCollection 2024.
3
Development and evaluation of INTGRATE: a platform for comprehensive assessment of the role of germline variants informed by tumor signature profile in Lynch syndrome.
INTGRATE的开发与评估:一个基于肿瘤特征谱信息全面评估种系变异在林奇综合征中作用的平台
Front Oncol. 2024 Jan 24;13:1284690. doi: 10.3389/fonc.2023.1284690. eCollection 2023.
4
Genomic disparity impacts variant classification of cancer susceptibility genes in Turkish breast cancer patients.基因组差异影响土耳其乳腺癌患者中癌症易感性基因变异的分类。
Cancer Med. 2024 Feb;13(3):e6852. doi: 10.1002/cam4.6852. Epub 2024 Feb 2.
5
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.卵巢癌病理学特征作为 BRCA1 和 BRCA2 变异致病性的预测因子。
Br J Cancer. 2023 Jun;128(12):2283-2294. doi: 10.1038/s41416-023-02263-5. Epub 2023 Apr 19.
6
Experiences of individuals with a variant of uncertain significance on genetic testing for hereditary cancer risks: a mixed method systematic review.遗传性癌症风险基因检测中意义未明变异个体的经历:一项混合方法的系统评价
J Community Genet. 2022 Aug;13(4):371-379. doi: 10.1007/s12687-022-00600-4. Epub 2022 Jul 12.
7
Cancer patients' understandings of genetic variants of uncertain significance in clinical care.癌症患者对临床护理中意义未明的基因变异的理解。
J Community Genet. 2022 Aug;13(4):381-388. doi: 10.1007/s12687-022-00594-z. Epub 2022 May 26.
8
Parental segregation study reveals rare benign and likely benign variants in a Brazilian cohort of rare diseases.父母分离研究揭示了巴西罕见疾病队列中的罕见良性和可能良性变异体。
Sci Rep. 2022 May 11;12(1):7764. doi: 10.1038/s41598-022-11932-z.
9
Physicians' experience, practice and education, on genetic testing and genetic counseling: a nationwide survey study in Greece.医生在基因检测和遗传咨询方面的经验、实践和教育:希腊全国调查研究。
Fam Cancer. 2022 Oct;21(4):479-487. doi: 10.1007/s10689-022-00290-4. Epub 2022 Jan 24.
10
Comprehensive Identification of Deleterious Missense VUS Variants Based on Their Impact on TP53 Structural Stability.基于对 TP53 结构稳定性的影响综合鉴定有害错义 VUS 变异。
Int J Mol Sci. 2021 Oct 20;22(21):11345. doi: 10.3390/ijms222111345.